Land: Svíþjóð
Tungumál: sænska
Heimild: Läkemedelsverket (Medical Products Agency)
influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat; influensavirus B/Hong Kong/330/2001-liknande stam (B/Shangdong/7/79), spjälkat virus, inaktiverat; influesavirus A/Moscow/10/99(H3N2)-liknande stam (A/Panama/2007/99 (RESVIR-17)), ytantigen, inaktiverat
Mimer Medical
J07BB02
influenza virus (A/New Caledonia/20/99 (H1N1)-like strain (A/New Caledonia/20/99 (IVR-116)), surface antigen, inactivated; influenza virus B/Hong-Kong -/330/2001- like strain (B/Shangdong/7/79), spjälkat virus, inactivated; influesavirus A/Moscow/10/99(H3N2)-like strain (A/Panama/2007/99 (RESVIR-17)), surface antigen, inactivated
Injektionsvätska, suspension, förfylld spruta
influensavirus B/Hong Kong/330/2001-liknande stam (B/Shangdong/7/79), spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influesavirus A/Moscow/10/99(H3N2)-liknande stam (A/Panama/2007/99 (RESVIR-17)), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat 15 mikrog Aktiv substans
Receptbelagt
spjälkat virus eller ytantigen
Avregistrerad
2004-10-29